摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[[(4S,5S)-2,2-二甲基-1,3-二氧戊环-4,5-二基]二(亚甲基)]二[二(4-甲氧基-3,5-二甲基苯基)-膦] | 127797-02-8

中文名称
[[(4S,5S)-2,2-二甲基-1,3-二氧戊环-4,5-二基]二(亚甲基)]二[二(4-甲氧基-3,5-二甲基苯基)-膦]
中文别名
——
英文名称
(4S,5S)-(-)-4,5-bis-2,2-dimethyl-1,3-dioxolane
英文别名
[(4S,5S)-5-[Bis(4-methoxy-3,5-dimethylphenyl)phosphanylmethyl]-2,2-dimethyl-1,3-dioxolan-4-yl]methyl-bis(4-methoxy-3,5-dimethylphenyl)phosphane
[[(4S,5S)-2,2-二甲基-1,3-二氧戊环-4,5-二基]二(亚甲基)]二[二(4-甲氧基-3,5-二甲基苯基)-膦]化学式
CAS
127797-02-8
化学式
C43H56O6P2
mdl
——
分子量
730.862
InChiKey
SKXXXRFPVHLNLJ-XPSQVAKYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    9
  • 重原子数:
    51
  • 可旋转键数:
    12
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    55.4
  • 氢给体数:
    0
  • 氢受体数:
    6

SDS

SDS:2d098ebcf2e8d58b64bfd96e7e7765b0
查看

反应信息

点击查看最新优质反应信息

文献信息

  • Process for the preparation of tricyclic amino alcohol derivatives
    申请人:ASAHI KASEI KABUSHIKI KAISHA
    公开号:US20030225289A1
    公开(公告)日:2003-12-04
    A process for the preparation of tricyclic amino alcohol derivatives including 2-[N-[2-(9H-carbazol-2-yloxy)ethyl]]amino-1-[(3-methylsulfonylamino)phenyl]ethanol useful in the treatment of diabetes, obesity, hyperlipidemia and so on; and intermediates as represented by formula (5) or (6) or the like useful in the preparation, wherein R11 is hydrogen or the like; and *1 represents an asymmetric carbon atom. 2-Halo-1-(3-nitrophenyl)ethanone derivatives and 1-(3-nitrophenyl)oxirane derivatives, which are intermediates for the preparation of tricyclic amino alcohol derivatives, are easy of purification, and particularly optically active 1-(3-nitrophenyl)oxirane derivatives are effective in enhancing the optical purities of the final products.
    一种用于制备包括2-[N-[2-(9H-咔唑-2-氧基)乙基]]基-1-[3-(甲磺酰基)苯基]乙醇在内的三环基醇衍生物的方法,该方法在治疗糖尿病、肥胖、高脂血症等方面有用;以及用公式(5)或(6)等表示的中间体,在制备中有用,其中R11是氢等;*1代表一个不对称碳原子。2-卤代-1-(3-硝基苯基)乙酮衍生物和1-(3-硝基苯基)环氧衍生物是用于制备三环基醇衍生物的中间体,易于纯化,特别是光学活性的1-(3-硝基苯基)环氧衍生物在提高最终产品的光学纯度方面是有效的。
  • METHOD FOR THE PREPARATION OF TRICYCLIC AMINO ALCOHOL DERIVATIVES THROUGH AZIDES
    申请人:Asahi Kasei Kabushiki Kaisha
    公开号:EP1174426A1
    公开(公告)日:2002-01-23
    The present invention is directed to processes for the preparation of a tricyclic amino-alcohol derivative useful for treating and preventing diabetes, obesity, hyperlipidemia and the like, which compound is represented by the formula (1): wherein R1 represents a lower alkyl group or a benzyl group; *1 represents an asymmetric carbon atom; R2 represents a hydrogen atom, a halogen atom or a hydroxyl group; and A represents one of the following groups: wherein X represents NH, O or S; R5 represents a hydrogen atom, a hydroxyl group, an amino group or an acetylamino group; and *2 represents an asymmetric carbon atom when R5 is not a hydrogen atom. The processes of the present invention proceed via azide derivatives and are convenient, practical preparing processes with low cost which comprise a small number of steps with good industrial work efficiency.
    本发明涉及一种用于治疗和预防糖尿病、肥胖、高脂血症等疾病的三环基醇衍生物的制备方法,该化合物由以下式子表示(1): 其中R1代表较低的烷基或苄基;*1代表一个不对称碳原子;R2代表氢原子、卤素原子或羟基;A代表以下其中一种基团: 其中X代表NH、O或S;R5代表氢原子、羟基、基或乙酰基;*2代表一个不对称碳原子,当R5不是氢原子时。本发明的方法通过叠氮生物进行,是方便、实用、成本低廉的制备方法,包括少量步骤且具有良好的工业工作效率。
  • PROCESS FOR THE PREPARATION OF TRICYCLIC AMINO ALCOHOL DERIVATIVES
    申请人:Asahi Kasei Kabushiki Kaisha
    公开号:EP1195371A1
    公开(公告)日:2002-04-10
    A process for the preparation of tricyclic amino alcohol derivatives of formula (1) or salts thereof which are useful in the treatment and prevention of diabetes, obesity, hyperlipidemia and so on; and intermediates useful for the process: wherein R1 is lower alkyl group or benzyl; *1 represents an asymmetric carbon atom; R2 is hydrogen, halogen, or hydroxyl; and A is one of the following groups: (wherein X is NH, O or S; R6 is hydrogen, hydroxyl, amino, or acetylamino; and *2 represents an asymmetric carbon atom when R6 is not hydrogen)
    一种用于制备式(1)的三环基醇衍生物或其盐的方法,该方法有助于治疗和预防糖尿病、肥胖、高脂血症等疾病;以及用于该方法的中间体:其中R1是较低的烷基或苄基;*1代表一个不对称碳原子;R2是氢、卤素或羟基;A是以下组之一:(其中X是NH、O或S;R6是氢、羟基、基或乙酰基;当R6不是氢时,*2代表一个不对称碳原子)
  • PROCESSES FOR THE PREPARATION OF TRICYCLIC AMINO ALCOHOL DERIVATIVES
    申请人:Asahi Kasei Kabushiki Kaisha
    公开号:EP1209150A1
    公开(公告)日:2002-05-29
    A process for the preparation of tricyclic amino alcohol derivatives including 2-[N-[2-(9H-carbazol-2-yloxy)ethyl]]amino-1-[(3-methylsulfonylamino)phenyl]ethanol useful in the treatment of diabetes, obesity, hyperlipidemia and so on; and intermediates as represented by formula (5) or (6) or the like useful in the preparation, wherein R11 is hydrogen or the like; and *1 represents an asymmetric carbon atom. 2-Halo-1-(3-nitrophenyl)ethanone derivatives and 1-(3-nitrophenyl)oxirane derivatives, which are intermediates for the preparation of tricyclic amino alcohol derivatives, are easy of purification, and particularly optically active 1-(3-nitrophenyl)oxirane derivatives are effective in enhancing the optical purities of the final products.
    一种制备三环基醇衍生物的工艺,包括用于治疗糖尿病、肥胖症、高脂血症等的2-[N-[2-(9H-咔唑-2-氧基)乙基]]基-1-[(3-甲磺酰基)苯基]乙醇;以及用于制备的式(5)或式(6)或类似物所代表的中间体,其中R11为氢或类似物;*1代表不对称碳原子。2-Halo-1-(3-nitrophenyl)ethanone 衍生物和 1-(3-硝基苯基)环氧乙烷生物是制备三环基醇衍生物的中间体,易于纯化,特别是具有光学活性的 1-(3-硝基苯基)环氧乙烷生物可有效提高最终产品的光学纯度。
  • US6696573B1
    申请人:——
    公开号:US6696573B1
    公开(公告)日:2004-02-24
查看更多

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯